2024    2023    2022    2021    2020    2019    2018    2017    2016   

2024

Articles

101 - 

Cryptococcus neoformans Infections Differ Among Human Immunodeficiency Virus (HIV)–Seropositive and HIV-Seronegative Individuals: Results From a Nationwide Surveillance Program in France

Olivier Paccoud, Marie Desnos-Ollivier, Sophie Cassaing, Karine Boukris-Sitbon, Alexandre Alanio et al.

Open Forum Infectious Diseases, 2024, 11 (2), pp.ofad658.

DOI : https://doi.org/10.1093/ofid/ofad658

Pubmed : 38344129

 

102 - 

Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial

Lionel Perrier, Frederic Balusson, Magali Morelle, Joël Castelli, Juliette Thariat et al.

Radiotherapy & Oncology, 2024, Radiotherapy and Oncology : Journal of the European Society For Therapeutic, 193, pp.110116.

DOI : https://doi.org/10.1016/j.radonc.2024.110116

Pubmed : 38316193

 

103 - 

Pregnancy and tobacco: practice and knowledge of French midwives.

Béatrice Pierrot, Guillaume Legendre, Jeremie Riou, Alexandra Gentil, Brigitte Molle-Guiliani et al.

Pregnancy and tobacco: practice and knowledge of French midwives. Midwifery, 2024, 129, pp.103886.

DOI : https://doi.org/10.1016/j.midw.2023.103886

Pubmed : 38041997

 

104 - 

Barriers to research findings utilization amongst critical care nurses and allied health professionals: An international survey

Laurent Poiroux, Arnaud Bruyneel, Lionel Larcin, Guillaume Fossat, Toufik Kamel et al.

Intensive and Critical Care Nursing, 2024, 81, pp.103610.

DOI : https://doi.org/10.1016/j.iccn.2023.103610

Pubmed : 38171952

 

105 - 

Promouvoir la recherche clinique en dermatologie libérale : freins et opportunités Promoting clinical research in private practice: Obstacles and opportunities

Florence Poizeau, A Maruani, Delphine Staumont-Sallé, N. Jouan, S. Ly et al.

Promouvoir la recherche clinique en dermatologie libérale : freins et opportunités. Annales de Dermatologie et de Vénéréologie - FMC, 2024,

DOI : https://doi.org/10.1016/j.fander.2023.11.001

 

106 - 

Optimization of Ganciclovir and Valganciclovir Starting Dose in Children by Machine Learning

Laure Ponthier, Julie Autmizguine, Bénédicte Franck, Anders Asberg, Philippe Ovetchkine et al.

Clinical Pharmacokinetics, 2024,

DOI : https://doi.org/10.1007/s40262-024-01362-7

Pubmed : 38492206

 

107 - 

Sex-related differences in pre-dialysis trajectories and dialysis initiation: A French nationwide retrospective study

Maxime Raffray, Louise Bourasseau, Cécile Vigneau, Cécile Couchoud, Clémence Béchade et al.

PLoS ONE, 2024, 19 (3), pp.e0299601.

DOI : https://doi.org/10.1371/journal.pone.0299601

Pubmed : 38536864

 

108 - 

Author Correction: Fungal Colonization of the Airways of Patients with Cystic Fibrosis: The Role of the Environmental Reservoirs

Kévin Ravenel, Hélène Guegan, Amandine Gastebois, Jean Philippe Bouchara, Jean Pierre Gangneux et al.

Mycopathologia, 2024, 189 (3), pp.36.

DOI : https://doi.org/10.1007/s11046-024-00841-6

 

109 - 

Fungal Colonization of the Airways of Patients with Cystic Fibrosis: the Role of the Environmental Reservoirs

Kévin Ravenel, Hélène Guegan, Amandine Gastebois, Jean-Philippe Bouchara, Jean-Pierre Gangneux et al.

Mycopathologia, 2024, Mycopathologia, 189 (2), pp.19.

DOI : https://doi.org/10.1007/s11046-023-00818-x

Pubmed : 38407729

 

110 - 

Human biomonitoring and toxicokinetics as key building blocks for next generation risk assessment

Elena Reale, Maryam Zare Jeddi, Alicia Paini, Alison Connolly, Radu Duca et al.

Environment International, 2024, 184, pp.108474.

DOI : https://doi.org/10.1016/j.envint.2024.108474